Health Encyclopedia

 

Health Encyclopedia Home



Immune Protein Found to Block HIV Spread in Some People

Immune Protein Found to Block HIV Spread in Some People

WEDNESDAY, Oct. 16 (HealthDay News) -- One percent of people infected with HIV have a second line of defense deep in their immune system, which serves as a back-up for the body's defenses that get wiped out by the virus, according to a new study.

These people, known as "controllers," are able to maintain long-term control of HIV without a daily regimen of antiviral medication because of a defensive immune protein, known as A3, which blocks the virus from spreading throughout their body.

Scientists from Northwestern University suggested their findings could help shorten the drug treatment required for others who have HIV, the virus that causes AIDS.

"Preserving and even increasing this defense in cells may make more HIV-infected persons into controllers and prevent HIV from rebounding to high and damaging levels when anti-HIV medications are stopped," the study's senior author, Dr. Richard D'Aquila, director of Northwestern's HIV Translational Research Center, said in a university news release.

In conducting the study, published online Oct. 16 in PLoS ONE, the researchers analyzed the cells of controllers in a lab. They found that these rare individuals have a greater supply of the A3 protein in specific white blood cells called resting memory T cells. Any new HIV made from those cells is rendered harmless by A3 and is unable to infect other cells.

Unlike other cells in the immune system that are unable to recognize HIV once it mutates, A3 is part of the so-called intrinsic immune system that isn't fooled by the virus. "The intrinsic immune system recognizes the basic guts of the virus -- the nucleic acids -- that HIV can't change and then damages those nucleic acids," D'Aquila explained.

The researchers suggested that earlier treatment could help others eventually maintain control of their HIV without medication by protecting their reserves of A3.

"Perhaps starting anti-HIV drugs very soon after HIV is caught, rather than the current practice of waiting until later to start, would work like the controllers' first line of defense," D'Aquila said. "If we preserve A3, it could minimize HIV's spread through the body as this protein seems to do in controllers."

The researchers noted there are several cases of early HIV treatment resulting in long-term control of the virus. For example, in January 2013, a baby born to an HIV-positive woman became infected with the virus but was given anti-HIV drug treatment within 36 hours of birth. That baby is now off antiviral medication and apparently cured of HIV, D'Aquila said.

If HIV remains unchecked for several months, however, the researchers suggested reserves of A3 are simply wiped out. They are currently working to develop a drug that would boost the A3 protein.

"Early-as-possible detection -- much easier with our new technology -- and early drug treatment will be the future of HIV therapy," D'Aquila concluded. He added that the new U.S. health law, the Affordable Care Act, now requires insurance companies to pay for routine HIV testing.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about treatment for HIV.

SOURCE: Northwestern University, news release, Oct. 16, 2013

 
Related Items
Wellness Library
  What You Need to Know About AIDS
  HIV Prevention Is Still Important
Content Type 134
  HIV/AIDS and Skin Conditions
  Dealing with Discrimination When You Have HIV
  When You’re HIV-Positive: What to Say
  Disorders of the Immune System
  AIDS-Related Malignancies
  Preventing Opportunistic Infections in HIV/AIDS
Drug Reference
  Somatrem, Recombinant, rh-GH
  Tipranavir
  Fosamprenavir
  Emtricitabine; Tenofovir
  Abacavir; Lamivudine, 3TC
  Darunavir
  Efavirenz; Emtricitabine; Tenofovir
  Maraviroc
  Raltegravir
  Etravirine
Quizzes
  HIV/AIDS Quiz
  HIV/AIDS and Seniors Quiz
Daily News Feed
  Researchers Describe 1st 'Functional Cure' of HIV in Baby
  Survival Picture No Better for Patients With HIV-Related Lymphoma: Study
  Rapid Test Detects HIV-1 and HIV-2 Antibodies and HIV-1 Antigen
  New Drug Approved to Treat HIV-1
  HIV Patients Get a Mental Lift From Exercise, Study Finds
  Early Course of HIV Therapy May Give Infants a Break From Drugs
  U.S. Circumcision Rates Drop by 10 Percent: CDC
  For Uninfected Partner, Antiretroviral Drugs May Shield Against HIV
  'Intensified' Global Effort Needed to Further Cut Child Deaths: Report
  Nail Fungus Drug Might Help Against HIV, Study Suggests
  AIDS Virus in Cats Might Help Human Vaccine Effort, Study Hints
  Meds That Prevent HIV Infection Don't Spur Risky Behavior: Study
  Scientists Uncover Breast Milk's Potential Secret Weapon Against HIV
  Counseling With HIV Testing May Not Help Prevent Future STDs
  Some 'High-Risk' Kidneys May Be Safe for Organ Transplant: Study
  Big Strides in Battle Against Pediatric AIDS
  Mother-Daughter Team Preaches the Gospel of HIV Prevention
  Child 'Cured' of HIV Remains Free of Virus, Doctors Report
  Early HIV Treatment a Win-Win, Researchers Report
  HIV Resistance Mapped by Gene Researchers
  Bisexual Men Aren't at Greater HIV Risk: Review
  Talking Openly With Partner Linked to HIV Testing in Teens
  New Clues to How Long-Term Drug Therapy Keeps HIV at Bay
  Multivitamins May Help Fight HIV Progression, Study Suggests
  Unprotected Sex On the Rise Among U.S. Gay Men, CDC Says
  New HIV Strain May Move to AIDS More Quickly: Study
  Taking Drug to Prevent HIV Doesn't Seem to Encourage Risk-Taking
  Abused Women Vulnerable to Unsafe Sex Practices
  Many Young Americans With HIV Delay Treatment: Study
  Only 1 in 3 HIV-Infected Black Americans Gets Effective Treatment: Study
  Higher HIV Infection Rates Seen in Mental Health Patients: Study
  Kids' Checkups Should Include Cholesterol, Depression Tests, Doctors Say
  Kids Born With HIV May Face Heart Risks Later, Study Suggests
  Long-Acting HIV Drug May Offer Better Protection Against Infection
  Gene Therapy for Controlling HIV Shows Early Promise
  Doctors Cautiously Optimistic About 'Cure' for HIV-Infected Babies
  Vaginal Gel Might Prevent HIV Hours After Exposure
  HIV Transmission Between Women Rare, But Possible: CDC
  Hepatitis C Patients With HIV May Face Higher Risk of Liver Disease
  Study Adds to Signs Linking HIV to Heart Trouble
  HIV-Positive Inmates Benefit From Drug Treatment, Study Says
  Driving Ability May Falter With Age in HIV-Positive Adults
  Scientists Map DNA of Deadly Fungus
  Slightly Higher Risk of Birth Defects Seen in Pregnant Women on HIV Drugs
  CDC Urges Anti-HIV Pill for People at High Risk of Infection
  Kids More Likely Than Adults To Be Resistant to HIV Meds: Study
  Many Unaware of Their HIV Status Until It's Advanced
  Study: Common HIV Drug May Boost Suicide Risk
  HIV Prevention Drug Truvada Might Lower Genital Herpes Risk, Too
  HIV Patients Less Likely to Get Cancer Treatment: Study
  Mississippi Girl Thought Cured of HIV Shows Signs of Infection
  AIDS Epidemic May Be Subsiding: Report
  Those With HIV Living Longer, International Study Finds
  Many Sexually Active U.S. Teens Not Tested for HIV: CDC
  HIV Diagnoses Down in U.S., Except for Young Gay Males: CDC
  Animal Experiments Shed Light on HIV's Ability to Hide
  Scientists Snipped HIV Out of Human DNA
Adult Diseases and Conditions
  HIV and AIDS
Pediatric Diseases and Conditions
  Acquired Immune Deficiency Syndrome (AIDS)/Human Immunodeficiency Virus (HIV)
  AIDS/HIV in Children